Science Explorer Back to mapMap
Discussion
Researcher · Princess Máxima Center · Netherlands

Friso Calkoen

Friso Calkoen publishes mostly in Oncology, Hematology and Immunology, on topics such as CAR-T cell therapy research, Acute Lymphoblastic Leukemia research and Glioma Diagnosis and Treatment.

ORCID 0000-0001-9059-0929 OpenAlex
World rank
#1,783,039
of 7,710,434 ranked researchers
Rank in Netherlands
#39,377
of 107,149
Works
83
Citations
679
Citations per work
8.2
h-index
15
i10-index 21Top 36% in Oncology
Friso Calkoen

What does Friso Calkoen research?

Friso Calkoen's work is mostly in Medicine (52%), Immunology and Microbiology (11%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 43 works · 51.7% of their workMedicine: 43 works · 51.7% of their workOncology: 19 works · 22.3% of their workHematology: 10 works · 12.3% of their workGenetics: 8 works · 10.0% of their workPublic Health, Environmental and Occupational Health: 6 works · 7.1% of their workEverything else: 24 works · 28.4% of their workLife Sciences: 17 works · 19.9% of their workImmunology and Microbiology: 9 works · 11.4% of their workImmunology: 9 works · 11.4% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 8.5% of their workMolecular Biology: 7 works · 8.5% of their workTHEIR WORKFriso Calkoen83works
Life Sciences20%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4351.7%
  2. Everything else2428.4%
    1. Immunology and Microbiology911.4%
    2. Biochemistry, Genetics and Molecular Biology78.5%
  1. 1Oncology22% of their works
  2. 2Hematology12% of their works
  3. 3Immunology11% of their works
  4. 4Genetics10% of their works
  5. 5Molecular Biology8% of their works
  6. 6Public Health, Environmental and Occupational Health7% of their works

Research topics

Which keywords describe Friso Calkoen's research?

The keywords of their largest research topics: Immunotherapy, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Prognostic Factors, Hematopoietic Stem Cells, Mesenchymal Stem Cells and Acute Lymphoblastic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Immunotherapy472 topics
  2. Cancer Immunotherapy402 topics
  3. CAR T Cells341 topic
  4. Chimeric Antigen Receptor341 topic
  5. Prognostic Factors222 topics
  6. Hematopoietic Stem Cells212 topics
  7. Mesenchymal Stem Cells212 topics
  8. Acute Lymphoblastic Leukemia141 topic
  9. Childhood Cancer141 topic
  10. Bone Marrow Niche131 topic
  11. Glioblastoma131 topic
  12. Graft-versus-Host Disease131 topic
  13. Temozolomide131 topic
  14. Gene Therapy91 topic
  15. Viral Vectors91 topic
  16. AML81 topic
  17. Acute Myeloid Leukemia81 topic
  18. Multipotent81 topic
  19. Regeneration81 topic
  20. Dendritic Cells61 topic
  21. Immunity61 topic

Where does Friso Calkoen work?

Friso Calkoen's main affiliation in the publication record is Princess Máxima Center, Netherlands.

How many publications and citations does Friso Calkoen have?

OpenAlex counts 83 works and 679 citations for Friso Calkoen, an h-index of 15, ranking #1,783,039 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Friso Calkoen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.